Reactive arthritis · Clinical perspective
Reactive Arthritis: A Clinical Decision Module
From a hot joint after infection to persistent SpA: diagnostic reasoning, treatment evidence and the decisions that change care.
Choose the clinical task
Read sequentially or enter at the decision you face. The opening framework and first-visit chapter are open access; other clinical chapters use the site’s Professional access. Patient explanations are freely available in English, Russian, Spanish and Polish.
Clinical chapters
Framework and phenotype
Reactive Arthritis Within the SpA Spectrum
An infection-linked syndrome needs a coherent phenotype, a plausible timeline and a diagnosis that remains open to revision.
Read chapter →Recognizing the Phenotype
Read the joints, entheses, eyes, skin and infection history together—without requiring the textbook triad.
Read chapter →Diagnosis and investigation
The First Visit: Establishing a Working Diagnosis
Resolve the dangerous alternatives, establish the inflammatory pattern and leave a testable explanation for the next visit.
Read chapter →Testing That Changes Management
The best investigation has a defined question, an appropriate specimen and a result that can change care.
Read chapter →Imaging With a Clinical Question
Use imaging to resolve anatomy, guide a procedure or investigate an evolving phenotype—not to manufacture diagnostic certainty.
Read chapter →Treat the infection and inflammation
Managing the Acute Inflammatory Episode
Control inflammation early enough to preserve movement and sleep, while keeping infection and medication safety in view.
Read chapter →Treating the Triggering Infection
Eradication, prevention of transmission and partner care have clear purposes—even when the effect on established arthritis is uncertain.
Read chapter →Prolonged Antibiotics: Evidence and Controversy
A positive small trial in a selected population deserves careful reading—not universal adoption or dismissal.
Read chapter →Persistent disease
Persistent Peripheral Arthritis: When to Use a DMARD
Escalation should follow demonstrable inflammation and its consequences, not the calendar alone.
Read chapter →Refractory Disease and Targeted Therapy
New treatment reports widen the discussion, but their designs determine how much confidence they deserve.
Read chapter →Longitudinal Care and Diagnostic Reassessment
Follow the inflammation, the person's function and the diagnosis itself—not just a single laboratory number.
Read chapter →Special Populations and Diagnostic Boundaries
Some patients need a modified pathway; some infection-associated arthritides need a different diagnosis altogether.
Read chapter →At the point of care
Investigation selector
Start from the clinical question, choose the specimen and define what the result will change.
Treatment evidence map
Study design, population, result and the limit on clinical inference.
Five clinical decisions
Short teaching scenarios with a decision, explanation and a change in management.
How this module handles uncertainty
This is an educational synthesis, not a systematic review. Sources prioritize original studies, professional guidelines and public-health guidance. US CDC infection recommendations and UK BASHH guidance are identified separately. Evidence from related SpA populations is labeled as extrapolation. No claim is made that a small uncontrolled study establishes efficacy or long-term safety.
Sources were checked on 2 October 2026. This is an independent educational synthesis; individual treatment still requires a clinical assessment.
Patient module and multilingual handouts →Clinical decision modules · English
Reactive arthritis · Professional quizzes
Work through diagnosis, investigation and treatment decisions. Access is shown for each module.
25 modules
A Trigger Is Not a Diagnosis
Phenotype, infection evidence and causal link are three separate claims.
Explore the quiz →Reviewed
Read the Whole Pattern
Joints, entheses, digits, eyes and skin — without waiting for the textbook triad.
Explore the quiz →Reviewed
Triage Before Attribution
At the first visit, a treatable joint infection matters more than a completed checklist.
Explore the quiz →Reviewed
If This Result Is Positive, I Will…
A defined question, the right specimen, and a result that can change care.
Play the open demo →Reviewed
An Image Is Not a Verdict
Imaging locates inflammation or damage; it rarely names the cause.
Explore the quiz →Reviewed
Two Tracks, One Plan
Treat the infection for its own indication and the inflammation for its severity.
Explore the quiz →Reviewed
Treat the Organism, Then the Joint
Eradication, transmission and partner care have clear purposes — whatever the joints do.
Explore the quiz →Reviewed
A Small Trial, Carefully Read
A positive signal in a selected population is neither a standard regimen nor a reason for dismissal.
Explore the quiz →Reviewed
Not by the Calendar Alone
Escalation follows demonstrable inflammation and its consequences.
Explore the quiz →Reviewed
Borrowed Evidence, Labeled as Such
A case report, a cohort and a randomized trial are not equivalent evidence.
Play the open demo →Reviewed
The Course Is Learned, Not Read
Follow the inflammation, the person's function and the diagnosis — not one laboratory number.
Explore the quiz →Reviewed
Which Process Has Returned?
A familiar patient does not guarantee a familiar cause.
Explore the quiz →Reviewed
Compatibility Is Not Interchangeable
Conception, pregnancy, breastfeeding and paternal exposure are four different questions.
Explore the quiz →Reviewed
Preserve the Other Differential
Children and immunocompromised patients need their own framework, not a stretched adult one.
Explore the quiz →Reviewed
When the Label Does Harm
Some infection-associated arthritides need a different diagnosis altogether.
Explore the quiz →Reviewed
Start With the Decision
A broad panel cannot substitute for aspiration, an exposure history or a defined alternative diagnosis.
Explore the quiz →Reviewed
Direct Is Not the Same as Certain
The strength of a treatment claim cannot exceed the design and population behind it.
Explore the quiz →Reviewed
What Must Happen Next?
The decisive question is often the next action, not the name of the disease.
Explore the quiz →Reviewed
Three Claims, Three Kinds of Evidence
The syndrome, the infection and the causal link are documented separately.
Explore the quiz →Reviewed
Rest Is a Dose, Not a Plan
Restore movement while inflammation is being treated.
Explore the quiz →Reviewed
Look Where It Is Concealed
Skin, mucosa and the back-pain history each need a deliberate examination of their own.
Explore the quiz →Reviewed
One Plan, Named Owners
An infection regimen belongs to a syndrome, a jurisdiction and a person responsible for follow-up.
Explore the quiz →Reviewed
The Prescription Is Half the Plan
A conventional DMARD is started together with its schedule, its monitoring and its review date.
Explore the quiz →Reviewed
A Trial You Can Review
Before the first dose: screening, a baseline, a review date and the conditions for stopping.
Explore the quiz →Reviewed
A Model Is Not a Test
Mechanisms of persistence explain the disease; they do not yet select a treatment for the individual.
Explore the quiz →Reviewed